P21WAF1/CIP1 protein and tongue cancer prognosis

被引:0
|
作者
Gonzalez-Moles, MA
Ruiz-Avila, I
Martinez, JAF
Gil-Montoya, JA
Esteban, F
Gonzalez-Moles, S
Bravo-Perez, M
Bascones, A
机构
[1] Univ Granada, Sch Dent, Dept Oral Med, E-18071 Granada, Spain
[2] Jaen Gen Hosp, Dept Pathol, Jaen, Spain
[3] Virgen Rocio Hosp, Dept Otolaryngol, Seville, Spain
[4] Univ Complutense Madrid, Sch Dent, Dept Oral Med & Periodontol, E-28040 Madrid, Spain
关键词
p21(waf1/cip1); tongue cancer; prognosis;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The expression of the cell cycle regulatory protein p21(waf1/cip1) was analyzed immunohistochemically in tissue from the tumor and adjacent non-tumor epithelia of 54 patients with tongue cancer in order to determine the proportion of tongue carcinomas with altered P21(waf1/cip1) expression, establish whether this alteration is an early event in tongue carcinogenesis and to investigate whether p21(waf1/cip1) expression has predictive prognostic value in these tumors. The percentage of p21(waf1/cip1)-positive neoplastic cells was calculated. Adjacent non-tumor epithelium was classified as normal, hyperplastic or dysplastic, and the p21(waf1/cip1) expression was only considered normal in suprabasal layers. P21(waf1/cip1) expression was negative in 57.4% (31/54) of the tumors and was aberrant in the non-tumor adjacent tissue of all patients studied. Neither the absence nor the degree of p21(waf1/cip1) expression influenced the survival of patients in the present series. P21(waf1/cip1) system alteration may be an early and frequent event in tongue carcinogenesis.
引用
收藏
页码:3225 / 3231
页数:7
相关论文
共 50 条
  • [21] p21Waf1/Cip1 deficiency stimulates centriole overduplication
    Duensing, Anette
    Ghanem, Louis
    Steinman, Richard A.
    Liu, Ying
    Duensing, Stefan
    CELL CYCLE, 2006, 5 (24) : 2899 - 2902
  • [22] Expression, purification and spectral characterization of p21Waf1/Cip1
    Shi Qiao-yun
    Zheng Yong-chen
    Ren Jin-song
    Qu Xiao-gang
    CHEMICAL RESEARCH IN CHINESE UNIVERSITIES, 2008, 24 (02) : 192 - 195
  • [23] A mimic of p21WAF1/CIP1 ameliorates murine lupus
    Goulvestre, C
    Chéreau, C
    Nicco, C
    Mouthon, L
    Weill, B
    Batteux, F
    JOURNAL OF IMMUNOLOGY, 2005, 175 (10): : 6959 - 6967
  • [24] Tumorigenic activity of p21Waf1/Cip1 in thymic lymphoma
    E De la Cueva
    I García-Cao
    M Herranz
    P López
    P García-Palencia
    J M Flores
    M Serrano
    J Fernández-Piqueras
    J Martín-Caballero
    Oncogene, 2006, 25 : 4128 - 4132
  • [25] The clinical value of p21WAF1/CIP1 expression in superficial bladder cancer
    Chow, NH
    Tzai, TS
    Cheng, HL
    Liu, HS
    Chan, SH
    Tong, YC
    ANTICANCER RESEARCH, 2000, 20 (2B) : 1173 - 1176
  • [26] p21Waf1/Cip1/Sdi1 mediates retinoblastoma protein degradation
    Broude, E. V.
    Swift, M. E.
    Vivo, C.
    Chang, B-D
    Davis, B. M.
    Kalurupalle, S.
    Blagosklonny, M. V.
    Roninson, I. B.
    ONCOGENE, 2007, 26 (48) : 6954 - 6958
  • [27] Expression, Purification and Spectral Characterization of p21Waf1/Cip1
    SHI Qiao-yun1
    2. Department of Central Laboratory
    Chemical Research in Chinese Universities, 2008, (02) : 192 - 195
  • [28] p21WAF1/CIP1与乳腺癌
    马双慰
    国外医学(生理、病理科学与临床分册), 2001, (06) : 493 - 495
  • [29] Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer
    Stein, JP
    Ginsberg, DA
    Grossfeld, GD
    Chatterjee, SJ
    Esrig, D
    Dickinson, MG
    Groshen, S
    Taylor, CR
    Jones, PA
    Skinner, DG
    Cote, RJ
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (14) : 1072 - 1079
  • [30] p21Waf1/Cip1: its paradoxical effect in the regulation of breast cancer
    Samir F. Zohny
    Abdulrahman L. Al-Malki
    Mazin A. Zamzami
    Hani Choudhry
    Breast Cancer, 2019, 26 : 131 - 137